col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

MDPI AG: Pharmaceutics
  original article Date Title Authors   All Authors
1 [GO] 2022―Jan―10 In Silico Evaluation of Binding of 2-Deoxy-D-Glucose with Mpro of nCoV to Combat COVID-19 Anirudh Pratap Singh Raman, Kamlesh Kumari, Pallavi Jain, Vijay Kumar Vishvakarma, Ajay Kumar, Neha Kaushik, et al. (+3)
2 [GO] 2021―Dec―09 Antiviral Activity of the Rhamnolipids Mixture from the Antarctic Bacterium Pseudomonas gessardii M15 against Herpes Simplex Viruses and Coronaviruses Rosa Giugliano, Carmine Buonocore, Carla Zannella, Annalisa Chianese, Fortunato Palma Esposito, Pietro Tedesco, et al. (+4)
3 [GO] 2021―Nov―03 Broad Spectrum Antiviral Properties of Cardiotonic Steroids Used as Potential Therapeutics for Emerging Coronavirus Infections Young-Hee Jin, Sangeun Jeon, Jihye Lee, Seungtaek Kim, Min Seong Jang, Chul Min Park, et al. (+3)
4 [GO] 2021―Oct―25 Early Effects of Low Molecular Weight Heparin Therapy with Soft-Mist Inhaler for COVID-19-Induced Hypoxemia: A Phase IIb Trial Mustafa Erelel, Mert Kaskal, Ozlem Akbal-Dagistan, Halim Issever, Ahmet Serhan Dagistanli, Hilal Balkanci, et al. (+12)
5 [GO] 2021―Oct―22 A Comprehensive Review about the Molecular Structure of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Insights into Natural Products against COVID-19 Essa M. Saied, Yousra A. El-Maradny, Alaa A. Osman, Amira M. G. Darwish, Hebatallah H. Abo Nahas, Gniewko Niedbała, et al. (+4)
6 [GO] 2021―Oct―12 Activation of Tenofovir Alafenamide and Sofosbuvir in the Human Lung and Its Implications in the Development of Nucleoside/Nucleotide Prodrugs for Treating SARS-CoV-2 Pulmonary Infection Jiapeng Li, Shuhan Liu, Jian Shi, Hao-Jie Zhu
7 [GO] 2021―Oct―09 Can the Nasal Cavity Help Tackle COVID-19? Bissera Pilicheva, Radka Boyuklieva
8 [GO] 2021―Sep―29 Evaluation of Aerosol Drug Delivery Options during Adult Mechanical Ventilation in the COVID-19 Era Piers J. Naughton, Mary Joyce, Marc Mac Giolla Eain, Andrew O’Sullivan, Ronan MacLoughlin
9 [GO] 2021―Sep―22 Exploring Drugs and Vaccines Associated with Altered Risks and Severity of COVID-19: A UK Biobank Cohort Study of All ATC Level-4 Drug Categories Reveals Repositioning Opportunities Yong Xiang, Kenneth Chi-Yin Wong, Hon-Cheong So
10 [GO] 2021―Sep―22 Functionalized Dendrimer Platforms as a New Forefront Arsenal Targeting SARS-CoV-2: An Opportunity Serge Mignani, Xiangyang Shi, Andrii Karpus, Giovanni Lentini, Jean-Pierre Majoral
11 [GO] 2021―Sep―18 Mesenchymal Stromal Cells: Potential Option for COVID-19 Treatment Dragan Primorac, Martin Čemerin, Vid Matišić, Vilim Molnar, Marko Strbad, Lenart Girandon, et al. (+4)
12 [GO] 2021―Sep―06 Combination Therapy with Fluoxetine and the Nucleoside Analog GS-441524 Exerts Synergistic Antiviral Effects against Different SARS-CoV-2 Variants In Vitro Linda Brunotte, Shuyu Zheng, Angeles Mecate-Zambrano, Jing Tang, Stephan Ludwig, Ursula Rescher, Sebastian Schloer
13 [GO] 2021―Aug―23 Model-Informed Repurposing of Medicines for SARS-CoV-2: Extrapolation of Antiviral Activity and Dose Rationale for Paediatric Patients Federico Romano, Salvatore D’Agate, Oscar Della Pasqua
14 [GO] 2021―Aug―16 Nebulised Isotonic Hydroxychloroquine Aerosols for Potential Treatment of COVID-19 Waiting Tai, Michael Yee Tak Chow, Rachel Yoon Kyung Chang, Patricia Tang, Igor Gonda, Robert B. MacArthur, et al. (+2)
15 [GO] 2021―Aug―02 Mathematical Modeling of Remdesivir to Treat COVID-19: Can Dosing Be Optimized? Jessica M. Conway, Pia Abel zur Wiesch
16 [GO] 2021―Jul―14 Inhalation Delivery for the Treatment and Prevention of COVID-19 Infection Basanth Babu Eedara, Wafaa Alabsi, David Encinas-Basurto, Robin Polt, Julie G. Ledford, Heidi M. Mansour
17 [GO] 2021―Jul―07 Pre-Drawn Syringes of Comirnaty for an Efficient COVID-19 Mass Vaccination: Demonstration of Stability Francesca Selmin, Umberto M. Musazzi, Silvia Franzè, Edoardo Scarpa, Loris Rizzello, Patrizia Procacci, Paola Minghetti
18 [GO] 2021―May―31 A Review of Repurposed Cancer Drugs in Clinical Trials for Potential Treatment of COVID-19 Bárbara Costa, Nuno Vale
19 [GO] 2021―May―27 Biomedical Text Link Prediction for Drug Discovery: A Case Study with COVID-19 Kevin McCoy, Sateesh Gudapati, Lawrence He, Elaina Horlander, David Kartchner, Soham Kulkarni, et al. (+7)
20 [GO] 2021―May―24 Lipophilicity, Pharmacokinetic Properties, and Molecular Docking Study on SARS-CoV-2 Target for Betulin Triazole Derivatives with Attached 1,4-Quinone Monika Kadela-Tomanek, Maria Jastrzębska, Krzysztof Marciniec, Elwira Chrobak, Ewa Bębenek, Stanisław Boryczka
21 [GO] 2021―Apr―14 Drug Repurposing for COVID-19 Treatment by Integrating Network Pharmacology and Transcriptomics Dan-Yang Liu, Jia-Chen Liu, Shuang Liang, Xiang-He Meng, Jonathan Greenbaum, Hong-Mei Xiao, et al. (+2)
22 [GO] 2021―Apr―07 Development of a Colorimetric Tool for SARS-CoV-2 and Other Respiratory Viruses Detection Using Sialic Acid Fabricated Gold Nanoparticles Haya A. Alfassam, Majed S. Nassar, Manal M. Almusaynid, Bashayer A. Khalifah, Abdullah S. Alshahrani, Fahad A. Almughem, et al. (+8)
23 [GO] 2021―Apr―05 Tackling Immune Pathogenesis of COVID-19 through Molecular Pharmaceutics Matteo Puccetti, Claudio Costantini, Maurizio Ricci, Stefano Giovagnoli
24 [GO] 2021―Apr―02 A COVID-19 Drug Repurposing Strategy through Quantitative Homological Similarities Using a Topological Data Analysis-Based Framework Raul Pérez-Moraga, Jaume Forés-Martos, Beatriz Suay-García, Jean-Louis Duval, Antonio Falcó, Joan Climent
25 [GO] 2021―Mar―08 Development and Characterization of Inhaled Ethanol as a Novel Pharmacological Strategy Currently Evaluated in a Phase II Clinical Trial for Early-Stage SARS-CoV-2 Infection Ana Castro-Balado, Cristina Mondelo-García, Letricia Barbosa-Pereira, Iria Varela-Rey, Ignacio Novo-Veleiro, Néstor Vázquez-Agra, et al. (+24)
26 [GO] 2021―Feb―26 Drug Repurposing in the COVID-19 Era: Insights from Case Studies Showing Pharmaceutical Peculiarities Milo Gatti, Fabrizio De De Ponti
27 [GO] 2021―Feb―26 Repurposing of Sitagliptin- Melittin Optimized Nanoformula against SARS-CoV-2: Antiviral Screening and Molecular Docking Studies Mohammed W. Al-Rabia, Nabil A. Alhakamy, Osama A. A. Ahmed, Khalid Eljaaly, Ahmed L. Aloafi, Ahmed Mostafa, et al. (+5)
28 [GO] 2020―Dec―22 Nuclear Medicine in Times of COVID-19: How Radiopharmaceuticals Could Help to Fight the Current and Future Pandemics Felix Neumaier, Boris D. Zlatopolskiy, Bernd Neumaier
29 [GO] 2020―Oct―05 COVID-19: Current Developments and Further Opportunities in Drug Delivery and Therapeutics Saman Zafar, Muhammad Sohail Arshad, Sameen Fatima, Amna Ali, Aliyah Zaman, Elshaimaa Sayed, et al. (+2)
30 [GO] 2020―May―11 MERS-CoV Spike Protein Vaccine and Inactivated Influenza Vaccine Formulated with Single Strand RNA Adjuvant Induce T-Cell Activation through Intranasal Immunization in Mice Hye-Jung Kim, Hye Won Kwak, Kyung Won Kang, Yoo-Jin Bang, Yu-Sun Lee, Hyeong-Jun Park, et al. (+5)


[de][en]

Last change 2021―Sep―04 16:13:39 UTC

© Daten-Quadrat 2021       Done in 0.006 sec